Summary
Entegris, Inc. (ENTG) announced on September 18, 2019, the acquisition of Hangzhou Anow Microfiltration Co., Ltd. for approximately $73 million in cash, subject to customary post-closing adjustments. This strategic move expands Entegris's presence in the critical filtration market, serving industries such as semiconductor, pharmaceutical, and medical. The acquisition is expected to bolster Entegris's product portfolio and market reach, particularly within the rapidly growing Asian markets. Investors should monitor the integration of Hangzhou Anow and its impact on Entegris's revenue growth, profitability, and overall market share in the specialized filtration sector.
Key Highlights
- 1Entegris acquired Hangzhou Anow Microfiltration Co., Ltd. for approximately $73 million in cash.
- 2Hangzhou Anow Microfiltration serves the semiconductor, pharmaceutical, and medical industries.
- 3The acquisition price is subject to certain post-closing adjustments.
- 4This move expands Entegris's filtration capabilities and market presence.
- 5The announcement was made via a press release filed on September 18, 2019.
Frequently Asked Questions
The acquisition of Hangzhou Anow Microfiltration Co., Ltd. is intended to strengthen Entegris's position in the filtration market, particularly by expanding its product offerings and geographic reach in key sectors like semiconductor, pharmaceutical, and medical, with a likely focus on the growing Asian market.
The acquisition was made for approximately $73 million in cash, with the final price subject to certain post-closing adjustments.
Hangzhou Anow Microfiltration Co., Ltd. serves industries including semiconductor, pharmaceutical, and medical.
The acquisition was announced on September 18, 2019.